deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants

deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank participants. The project will allow the complete sequencing of the genetic code of all 500,000 participants in the UK Biobank. This challenging project represents the single most ambitious sequencing program ever undertaken in the world.

The UK Biobank is an extraordinary resource for medical research that Great Britain has built over the past 15 years. Furthermore, Great Britain has set an example by unselfishly making it available to scientists from all over the world.

The Whole Genome Sequencing of the UK Biobank participants will be performed by deCODE genetics together with the Wellcome Sanger Institute in the UK with an anticipated completion in the summer of 2021. This project will dramatically enhance the value of the UK Biobank's uniquely rich data resource and will become a game-changing resource accessible to the global scientific community to understand, diagnose, treat and prevent life-changing diseases such as cancer and dementia.

The scale of the sequencing program presents unique challenges particularly in the way that the vast amounts of data are generated, stored and analyzed. deCODE has built a sequencing and analytical capacity required to execute this challenging project. The total amount of genetic data generated are roughly equivalent to around 5,000 billion pages of text and that will be linked to the detailed clinical and lifestyle data for each participant in the UK Biobank program.

"deCODE is taking human genetic research to a new level, applying the methods we pioneered in Iceland to lead a worldwide search for disease genes," said Kari Stefansson, CEO of deCODE Genetics, a wholly-owned subsidiary of Amgen. "As drug development programs backed by genetics are twice as likely to succeed, our sequencing capabilities will be essential to the consortium, and the broader scientific community, to identify and validate promising drug targets for some of the most challenging diseases."

About deCODE
Based in Reykjavik, Iceland, deCODE is a global leader in human genetics. Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases. One of the purposes of understanding the genetics of disease is to use it to invent new means of diagnosing, treating and preventing disease. deCODE is a wholly-owned subsidiary of Amgen (NASDAQ: AMGN).

Tags : #decode #iceland #agrees-to-sequence

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024
Will #PutPeopleFirst mantra drive HIV responses?July 10, 2024
Shiprocket and Snowflake AI Data Cloud to empower 1.5 lakh merchants of BHARAT to scale their data infrastructureJuly 10, 2024
Dr. Shilpa Vora, Marico expert shares tips on how you can safeguard your baby’s skin during the monsoon seasonJuly 10, 2024
Pre Budget 2024 (Ms. Deepshikha Sharma- CEO of Sharp Sight Eye Hospital) July 10, 2024
Rate of global warming caused by humans at an all-time high - research led by University of LeedsJuly 09, 2024
Dengue during Monsoon Season and Neurological Complications Associated with DengueJuly 09, 2024
Yodda Elder Care Renews Partnership with Medulance for Emergency ServicesJuly 09, 2024
Budget Expectation Quote- Dr. Sanjeev Singh, Medical Director, Amrita Hospital, FaridabadJuly 08, 2024
Honourable Justice R. Mahadevan, Chief Justice of Madras High Court, Chennai Inaugurates IIRSI 2024, India's Premier Convention on Eye SurgeryJuly 06, 2024
The Impact of Architecture on Academic Performance: How Exam Hall Design Affects Student SuccessJuly 06, 2024
Teen Dies from Brain-Eating Amoeba in Kerala: Fatal Naegleria fowleri Infections SurgeJuly 05, 2024
Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer SurvivorsJuly 05, 2024
Qatar Airways Chooses Çelebi India as Ground Handler for New Doha-Goa FlightsJuly 04, 2024
Zika Virus Alert in Maharashtra: Government's Proactive Steps for Public SafetyJuly 04, 2024